284040-67-1 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
5-chloro-3,3'-bipyridine is used as a building block for the synthesis of various pharmaceuticals and agrochemicals due to its ability to form coordination complexes with metal ions, enhancing the properties of the final products.
Used in Coordination Chemistry:
5-chloro-3,3'-bipyridine is used as a ligand for forming coordination complexes with metal ions, which is crucial in the study and application of coordination chemistry for various purposes, including catalysis and material science.
Used in Catalysis:
As a ligand in catalytic reactions, 5-chloro-3,3'-bipyridine is employed to improve the efficiency and selectivity of chemical transformations, contributing to greener and more sustainable chemical processes.
Used in the Preparation of Heterocyclic Compounds:
5-chloro-3,3'-bipyridine is used as a precursor in the synthesis of heterocyclic compounds, which are important in various fields such as medicinal chemistry and materials science.
Used in Biological Research:
5-chloro-3,3'-bipyridine is studied for its potential biological activities, such as anti-inflammatory and antitumor properties, indicating its use in the development of new therapeutic agents.
Overall, 5-chloro-3,3'-bipyridine's multifaceted applications make it a significant compound in both academic research and industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 284040-67-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,4,0,4 and 0 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 284040-67:
(8*2)+(7*8)+(6*4)+(5*0)+(4*4)+(3*0)+(2*6)+(1*7)=131
131 % 10 = 1
So 284040-67-1 is a valid CAS Registry Number.
284040-67-1Relevant academic research and scientific papers
Novel potent ligands for the central nicotinic acetylcholine receptor: Synthesis, receptor binding, and 3D-QSAR analysis
Nielsen, Simon Feldb?k,Nielsen, Elsebet ?stergaard,Olsen, Gunnar M.,Liljefors, Tommy,Peters, Dan
, p. 2217 - 2226 (2007/10/03)
In the past few years the focus on central acetylcholine receptors has shifted from-compounds with affinity for muscarinic acetylcholine receptors (mAChR) to compounds with affinity for nicotinic acetylcholine receptors (nAChR). The therapeutic potential
